Metabolism of nitrosamines and aflatoxin B1 by hamster liver CYP2A enzymes
Identifieur interne : 000337 ( France/Analysis ); précédent : 000336; suivant : 000338Metabolism of nitrosamines and aflatoxin B1 by hamster liver CYP2A enzymes
Auteurs : P Ivi Pelkonen [Finlande] ; Gordon M. Kirby [Canada] ; Christopher P. Wild [France] ; Helmut Bartsch [France] ; Matti A. Lang [France]Source :
- Chemico-Biological Interactions [ 0009-2797 ] ; 1994.
Descripteurs français
- Wicri :
- topic : Règlement.
English descriptors
- KwdEn :
Abstract
Using a specific antibody against mouse CYP2A5 and coumarin as inhibitors, and pretreatments known to affect the activities of CYP2A-related enzymes, we studied the contribution of hamster liver CYP2As in the dealkylation of N-nitrosodimethylamine (NDMA), N-nitrosodiethylamine (NDEA) and hydroxylation of aflatoxin B1 (AFB1). CYP2A5 antibody inhibited AFB1 and NDEA metabolism by 40–60% in untreated hamsters and after treatment with phenobarbital (PB) or 3-methylcholanthrene (MC). After pyrazole (PYR) treatment, there was no inhibition, although PYR increased the metabolism above the controls. NDMA metabolism was inhibited only weakly in all groups. This suggests that CYP2As may contribute significantly to NDEA and AFB1 metabolism and less to NDMA metabolism in untreated hamster liver and after MC or PB treatments, but that PYR treatment may change the expression pattern of CYPs so that the metabolism is mainly catalysed by CYPs not recognized by the antibody. Coumarin inhibited NDEA and NDMA metabolism in all groups of hamsters, including pyrazole-pretreated animals, suggesting that it interacts not only with CYP2As but also with other CYPs that are important in nitrosamine metabolism. On the other hand, coumarin inhibited AFB1 metabolism significantly only in control and PB-treated animals but not at all after PYR or MC treatment. This suggests that enzymes involved in AFB1 metabolism may be different depending on the pretreatment. It is concluded that CYP2As may contribute significantly to nitrosamine and aflatoxin metabolism in hamster liver. However, in view of previous results showing essential differences in their regulation between mouse and hamster, interspecies comparisons may be difficult.
Url:
DOI: 10.1016/0009-2797(94)90084-1
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002453
- to stream Istex, to step Curation: 002453
- to stream Istex, to step Checkpoint: 001B66
- to stream Main, to step Merge: 004996
- to stream Main, to step Curation: 004239
- to stream Main, to step Exploration: 004239
- to stream France, to step Extraction: 000337
Links to Exploration step
ISTEX:AAB996946E32941DC408806B44DB8E2671CB67BCLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Metabolism of nitrosamines and aflatoxin B1 by hamster liver CYP2A enzymes</title><author><name sortKey="Pelkonen, P Ivi" sort="Pelkonen, P Ivi" uniqKey="Pelkonen P" first="P Ivi" last="Pelkonen">P Ivi Pelkonen</name></author><author><name sortKey="Kirby, Gordon M" sort="Kirby, Gordon M" uniqKey="Kirby G" first="Gordon M." last="Kirby">Gordon M. Kirby</name></author><author><name sortKey="Wild, Christopher P" sort="Wild, Christopher P" uniqKey="Wild C" first="Christopher P." last="Wild">Christopher P. Wild</name></author><author><name sortKey="Bartsch, Helmut" sort="Bartsch, Helmut" uniqKey="Bartsch H" first="Helmut" last="Bartsch">Helmut Bartsch</name></author><author><name sortKey="Lang, Matti A" sort="Lang, Matti A" uniqKey="Lang M" first="Matti A." last="Lang">Matti A. Lang</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:AAB996946E32941DC408806B44DB8E2671CB67BC</idno><date when="1994" year="1994">1994</date><idno type="doi">10.1016/0009-2797(94)90084-1</idno><idno type="url">https://api-v5.istex.fr/document/AAB996946E32941DC408806B44DB8E2671CB67BC/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002453</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002453</idno><idno type="wicri:Area/Istex/Curation">002453</idno><idno type="wicri:Area/Istex/Checkpoint">001B66</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001B66</idno><idno type="wicri:doubleKey">0009-2797:1994:Pelkonen P:metabolism:of:nitrosamines</idno><idno type="wicri:Area/Main/Merge">004996</idno><idno type="wicri:Area/Main/Curation">004239</idno><idno type="wicri:Area/Main/Exploration">004239</idno><idno type="wicri:Area/France/Extraction">000337</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Metabolism of nitrosamines and aflatoxin B1 by hamster liver CYP2A enzymes</title><author><name sortKey="Pelkonen, P Ivi" sort="Pelkonen, P Ivi" uniqKey="Pelkonen P" first="P Ivi" last="Pelkonen">P Ivi Pelkonen</name><affiliation wicri:level="1"><country xml:lang="fr">Finlande</country><wicri:regionArea>University of Kuopio, Department of Pharmacology and Toxicology, P.O. Box 1627, SF 70211 Kuopio</wicri:regionArea><wicri:noRegion>SF 70211 Kuopio</wicri:noRegion></affiliation></author><author><name sortKey="Kirby, Gordon M" sort="Kirby, Gordon M" uniqKey="Kirby G" first="Gordon M." last="Kirby">Gordon M. Kirby</name><affiliation wicri:level="3"><country>Canada</country><wicri:regionArea>Lady Davis Research Institute, 3755 Cote St. Catherine Road, Montreal</wicri:regionArea><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author><author><name sortKey="Wild, Christopher P" sort="Wild, Christopher P" uniqKey="Wild C" first="Christopher P." last="Wild">Christopher P. Wild</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon, Cedex 08</wicri:regionArea><wicri:noRegion>Cedex 08</wicri:noRegion><wicri:noRegion>Cedex 08</wicri:noRegion></affiliation></author><author><name sortKey="Bartsch, Helmut" sort="Bartsch, Helmut" uniqKey="Bartsch H" first="Helmut" last="Bartsch">Helmut Bartsch</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon, Cedex 08</wicri:regionArea><wicri:noRegion>Cedex 08</wicri:noRegion><wicri:noRegion>Cedex 08</wicri:noRegion></affiliation></author><author><name sortKey="Lang, Matti A" sort="Lang, Matti A" uniqKey="Lang M" first="Matti A." last="Lang">Matti A. Lang</name><affiliation></affiliation><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon, Cedex 08</wicri:regionArea><wicri:noRegion>Cedex 08</wicri:noRegion><wicri:noRegion>Cedex 08</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Chemico-Biological Interactions</title><title level="j" type="abbrev">CBI</title><idno type="ISSN">0009-2797</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1994">1994</date><biblScope unit="volume">93</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="41">41</biblScope><biblScope unit="page" to="50">50</biblScope></imprint><idno type="ISSN">0009-2797</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0009-2797</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AFB1</term><term>COH</term><term>CYP</term><term>CYP2A</term><term>CYP2A4</term><term>CYP2A5</term><term>CYPs 2A</term><term>Carcinogen metabolism</term><term>Hamster</term><term>MC</term><term>NDEA</term><term>NDMA</term><term>P450</term><term>PB</term><term>PYR</term><term>Regulation</term><term>SDS-PAGE</term><term>T15α</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Règlement</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Using a specific antibody against mouse CYP2A5 and coumarin as inhibitors, and pretreatments known to affect the activities of CYP2A-related enzymes, we studied the contribution of hamster liver CYP2As in the dealkylation of N-nitrosodimethylamine (NDMA), N-nitrosodiethylamine (NDEA) and hydroxylation of aflatoxin B1 (AFB1). CYP2A5 antibody inhibited AFB1 and NDEA metabolism by 40–60% in untreated hamsters and after treatment with phenobarbital (PB) or 3-methylcholanthrene (MC). After pyrazole (PYR) treatment, there was no inhibition, although PYR increased the metabolism above the controls. NDMA metabolism was inhibited only weakly in all groups. This suggests that CYP2As may contribute significantly to NDEA and AFB1 metabolism and less to NDMA metabolism in untreated hamster liver and after MC or PB treatments, but that PYR treatment may change the expression pattern of CYPs so that the metabolism is mainly catalysed by CYPs not recognized by the antibody. Coumarin inhibited NDEA and NDMA metabolism in all groups of hamsters, including pyrazole-pretreated animals, suggesting that it interacts not only with CYP2As but also with other CYPs that are important in nitrosamine metabolism. On the other hand, coumarin inhibited AFB1 metabolism significantly only in control and PB-treated animals but not at all after PYR or MC treatment. This suggests that enzymes involved in AFB1 metabolism may be different depending on the pretreatment. It is concluded that CYP2As may contribute significantly to nitrosamine and aflatoxin metabolism in hamster liver. However, in view of previous results showing essential differences in their regulation between mouse and hamster, interspecies comparisons may be difficult.</div></front></TEI><affiliations><list><country><li>Canada</li><li>Finlande</li><li>France</li></country><region><li>Québec</li></region><settlement><li>Montréal</li></settlement></list><tree><country name="Finlande"><noRegion><name sortKey="Pelkonen, P Ivi" sort="Pelkonen, P Ivi" uniqKey="Pelkonen P" first="P Ivi" last="Pelkonen">P Ivi Pelkonen</name></noRegion></country><country name="Canada"><region name="Québec"><name sortKey="Kirby, Gordon M" sort="Kirby, Gordon M" uniqKey="Kirby G" first="Gordon M." last="Kirby">Gordon M. Kirby</name></region></country><country name="France"><noRegion><name sortKey="Wild, Christopher P" sort="Wild, Christopher P" uniqKey="Wild C" first="Christopher P." last="Wild">Christopher P. Wild</name></noRegion><name sortKey="Bartsch, Helmut" sort="Bartsch, Helmut" uniqKey="Bartsch H" first="Helmut" last="Bartsch">Helmut Bartsch</name><name sortKey="Lang, Matti A" sort="Lang, Matti A" uniqKey="Lang M" first="Matti A." last="Lang">Matti A. Lang</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000337 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000337 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= France
|étape= Analysis
|type= RBID
|clé= ISTEX:AAB996946E32941DC408806B44DB8E2671CB67BC
|texte= Metabolism of nitrosamines and aflatoxin B1 by hamster liver CYP2A enzymes
}}
| This area was generated with Dilib version V0.6.29. |  |